These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24730717)

  • 1. Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study.
    Forlenza OV; Coutinho AM; Aprahamian I; Prando S; Mendes LL; Diniz BS; Gattaz WF; Buchpiguel CA
    ACS Chem Neurosci; 2014 Jun; 5(6):484-9. PubMed ID: 24730717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer's disease.
    Choi H; Choi Y; Lee EJ; Kim H; Lee Y; Kwon S; Hwang DW; Lee DS;
    J Neuroinflammation; 2021 Aug; 18(1):190. PubMed ID: 34465358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study.
    Tondo G; Boccalini C; Caminiti SP; Presotto L; Filippi M; Magnani G; Frisoni GB; Iannaccone S; Perani D
    J Alzheimers Dis; 2021; 80(1):433-445. PubMed ID: 33579848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging.
    Ercoli LM; Small GW; Siddarth P; Kepe V; Huang SC; Miller KJ; Lavretsky H; Bookheimer SY; Barrio JR; Silverman DH
    Int J Geriatr Psychiatry; 2012 Oct; 27(10):1017-27. PubMed ID: 22383132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterizing the normative profile of 18F-FDG PET brain imaging: sex difference, aging effect, and cognitive reserve.
    Yoshizawa H; Gazes Y; Stern Y; Miyata Y; Uchiyama S
    Psychiatry Res; 2014 Jan; 221(1):78-85. PubMed ID: 24262800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients.
    Jiménez-Bonilla JF; Banzo I; De Arcocha-Torres M; Quirce R; Martínez-Rodríguez I; Lavado-Pérez C; Bravo-Ferrer Z; Rodríguez-Rodríguez E; Sánchez-Juan P; Carril JM
    Nucl Med Commun; 2016 Nov; 37(11):1189-96. PubMed ID: 27341411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia.
    Oh JS; Oh M; Chung SJ; Kim JS
    Neuroreport; 2014 Oct; 25(15):1198-202. PubMed ID: 25144395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture.
    Liu W; Zhuo P; Li L; Jin H; Lin B; Zhang Y; Liang S; Wu J; Huang J; Wang Z; Lin R; Chen L; Tao J
    Free Radic Biol Med; 2017 Nov; 112():174-190. PubMed ID: 28756309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial spin labeling versus
    Dolui S; Li Z; Nasrallah IM; Detre JA; Wolk DA
    Neuroimage Clin; 2020; 25():102146. PubMed ID: 31931403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial.
    Forlenza OV; Radanovic M; Talib LL; Gattaz WF
    Br J Psychiatry; 2019 Nov; 215(5):668-674. PubMed ID: 30947755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Modifiable Lifestyle Factors With Cortical Amyloid Burden and Cerebral Glucose Metabolism in Older Adults With Mild Cognitive Impairment.
    Kimura N; Aso Y; Yabuuchi K; Ishibashi M; Hori D; Sasaki Y; Nakamichi A; Uesugi S; Jikumaru M; Sumi K; Eguchi A; Obara H; Kakuma T; Matsubara E
    JAMA Netw Open; 2020 Jun; 3(6):e205719. PubMed ID: 32515796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment.
    Brück A; Virta JR; Koivunen J; Koikkalainen J; Scheinin NM; Helenius H; Någren K; Helin S; Parkkola R; Viitanen M; Rinne JO
    Eur J Nucl Med Mol Imaging; 2013 Oct; 40(10):1567-72. PubMed ID: 23801168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Alzheimers Dis; 2016 Apr; 52(4):1385-401. PubMed ID: 27079727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion.
    Lange C; Suppa P; Frings L; Brenner W; Spies L; Buchert R
    J Alzheimers Dis; 2016; 49(4):945-959. PubMed ID: 26577523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
    Frings L; Hellwig S; Bormann T; Spehl TS; Buchert R; Meyer PT
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1442-1448. PubMed ID: 29546632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.
    Yakushev I; Schreckenberger M; Müller MJ; Schermuly I; Cumming P; Stoeter P; Gerhard A; Fellgiebel A
    Eur J Nucl Med Mol Imaging; 2011 Dec; 38(12):2219-27. PubMed ID: 21792570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.